Plasminogen Activator Inhibitor-1 in Skin Malignancies: Therapeutic Implications of Its Inhibition

Plasminogen activator inhibitor-1 (PAI-1), a key regulator of fibrinolysis, has emerged as a critical stromal factor that contributes to tumor progression in various malignancies, including skin cancers. Beyond its classical role in inhibiting plasminogen activators, PAI-1 exerts pleiotropic effects...

Descrición completa

Detalles Bibliográficos

Principais autores:	Taku Fujimura, Yusuke Muto, Yoshihide Asano
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2025-09-01
Series:	Biomolecules
Assuntos:	PAI-1 tumor microenvironment SASP melanoma immune checkpoints angiogenesis
Acceso en liña:	https://www.mdpi.com/2218-273X/15/9/1317
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!